MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Biocon
Biocon
BSE: 532523|NSE: BIOCON|ISIN: INE376G01013|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 24, 17:00
274.40
-1.2 (-0.44%)
VOLUME 18,311
LIVE
NSE
May 24, 17:00
274.50
-2.6 (-0.94%)
VOLUME 214,093
News on Biocon
Select Year: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Low cost healthcare, not just price curbs, needed: Biocon  

1.34 pm | 20 May 2013 |  Source: CNBC-TV18

The new drug policy is unfavourable to big players feels Kiran Mazumdar Shaw, but adds that Biocon will not be impacted significantly by it....

Buy Tata Global, Divis Labs, Bombay Burmah: Merani 

12.39 pm | 29 Apr 2013 |  Source: CNBC-TV18

In CNBC-TV18's popular show Bull's Eye, Nooresh Merani, AMSEC Research shares his trading strategies for the day....

Bull's Eye: Buy Tata Global, SpiceJet, Bombay Burmah 

9.02 am | 29 Apr 2013 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

Biocon appoints Daniel M Bradbury as additional director

11.50 am | 26 Apr 2013 |  Source: Moneycontrol.com

Biocon at its meeting held on April 25, 2013 has appointed Mr Daniel M Bradbury as an additional director of the company. He will hold office up to th...

Biocon recommends 100% final dividend

11.50 am | 26 Apr 2013 |  Source: Moneycontrol.com

Biocon at its meeting held on April 25, 2013 has recommended a final dividend of Rs 5 per share (i.e. 100%) and a special dividend of Rs 2.50 per shar...

Biocon Q4 net jumps on exceptional gains; EBITDA down 21% 

10.00 am | 26 Apr 2013 |  Source: Moneycontrol.com

Biocon's fourth quarter consolidated net profit grew 2.5 times year-on-year to Rs 249 crore, boosted by one time exceptional income of Rs 202 crore. ...

Bull's Eye: Buy Idea, IVRCL, Jubilant Fooworks 

9.32 am | 26 Apr 2013 |  Source: Moneycontrol.com

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

6 trading stocks for short term gain 

8.51 am | 26 Apr 2013 |  Source: CNBC-TV18

On CNBC-TV18's show Super Six, market gurus Rajesh Jain, Religare Securities, Vikrant Jadeja, vibranttrades.com and Vishal Malkan, malkansview.com, pl...

Stocks in news: Hikal, NIIT Tech, Alok, Biocon, Idea, IDBI

8.51 am | 26 Apr 2013 |  Source: CNBC-TV18

Hikal | Castrol India | NIIT Tech | JSW Steel | Alok Industries | Biocon | United Spirits | Asian Paints | IDBI Bank | Idea Cellular | JSPL and Maruti...

Biocon Q4: Analysts expect 9% drop in PAT to Rs 89.4cr

7.00 pm | 23 Apr 2013 |  Source: CNBC-TV18

Pharmaceutical firm Biocon is set to declare its fourth quarter FY13 numbers on Thursday. Analysts on an average expect the company's profit after tax...

Pharma cos likely to post 21% EBITDA growth in Q4: MOST

1.30 pm | 16 Apr 2013 |  Source: Moneycontrol.com

Motilal Oswal has come with its March`13 quarterly earning estimates for healthcare sector. The research firm expects a top line growth of 17.4% YoY a...

Buy Biocon above Rs 272; target Rs 288: IIFL

1.27 pm | 06 Mar 2013 |  Source: Moneycontrol.com

IIFL is bullish on Biocon and has recommended to buy the stock above Rs 272 with a stop loss of Rs 264 for the target price of Rs 288, in its March 06...

Hold Biocon; target of Rs 312: Sushil Finance

12.31 pm | 30 Jan 2013 |  Source: Moneycontrol.com

Sushil Finance has recommended hold rating on Biocon with a target of Rs 312, in its January 29, 2013 research report....

Motilal Oswal neutral on Biocon

12.29 pm | 30 Jan 2013 |  Source: Moneycontrol.com

Motilal Oswal has maintained neutral rating on Biocon with a target of Rs 315 in its January 28, 2013 research report....

Accumulate Biocon; target of Rs 312: Dolat Capital

1.27 pm | 29 Jan 2013 |  Source: Moneycontrol.com

Dolat Capital is bullish on Biocon and has recommended accumulate rating on the stock with a target of Rs 312 in its January 28, 2013 research report....

Revised: Biocon Q3 net rises 9%; input costs shrink margins 

1.09 pm | 25 Jan 2013 |  Source: Moneycontrol.com

Biocon's third quarter (October-December) quarter grew 9 percent year-on-year to Rs 93 crore, as higher expenses compressed margins and offset a good ...

Revised: Biocon Q3 net rises 9%; input costs shrink margins 

9.12 am | 25 Jan 2013 |  Source: Moneycontrol.com

Biocon group has posted a consolidated net profit after tax and minority interest of Rs 91.76 crore, up 8.14% for the quarter ended December 31, 2012 ...

Biocon Q3: Analysts expect PAT growing 6% to Rs 90 cr

10.13 am | 24 Jan 2013 |  Source: CNBC-TV18

Healthcare firm Biocon is set to declare its third quarter results on Thursday. Analysts on an average expect profit after tax of the company to grow ...

See pharma sector's Q3 topline to grow 22%: Motilal Oswal

11.54 am | 12 Jan 2013 |  Source: Moneycontrol.com

Motilal Oswal has come out with its earnings estimates for pharmaceuticals sector for the quarter ended December 2012. The research firm expects the t...

1 2 3
Quick Links for Biocon
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.